Advertisement

Topics

Dynavax Technologies Company Profile

15:04 EDT 19th September 2017 | BioPortfolio

Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative therapeutic products to treat and prevent infectious diseases, allergies, and cancer. Our versatile, proprietary approaches alter specific immune responses by activating a unique receptor called Toll-Like Receptor 9 (TLR9) found on certain immune system cells. To target TLR9, we are using immunostimulatory sequences, or ISS, which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation. Our clinical development pipeline includes: HEPLISAV™, a hepatitis B vaccine in Phase 3 clinical trials; TOLAMBA™, a ragweed allergy immunotherapeutic; a hepatitis B therapy in a Phase 1 trial; and a cancer therapy for non-Hodgkin's lymphoma (NHL) in a Phase 2 trial and for metastatic colorectal cancer in a Phase 1 trial. Our preclinical program in asthma and chronic obstructive pulmonary disease (COPD) is partnered with AstraZeneca. Our preclinical work on an influenza vaccine is funded in part by the National Institutes of Health (NIH), while our colorectal cancer clinical trial and preclinical hepatitis C therapeutic program are funded by Symphony Dynamo, Inc. While the NIH and Symphony provide program support, Dynavax has retained rights to seek strategic partners for future development and commercialization.

Location

2929 Seventh Street, Suite 100
Berkeley
CA
94710
United States of America

Contact

Phone: +1.510.848.5100
Fax: +1.510.848.1327
Email: contact@dynavax.com


News Articles [489 Associated News Articles listed on BioPortfolio]

Company Spotlight: Dynavax

Shares of Dynavax Technologies Corp. (DVAX) are up a whopping 306% year-to-date while the iShares Nasdaq Biotechnology Index (ETF) has gained only 19% during the same period.

Dynavax Technologies (DVAX) Announces Positive Melanoma Results In Early Stage Study

Dynavax Technologies (NASDAQ:DVAX) announced positive phase 1b/2 results in patients with melanoma. The trial was testing a combination of Dynavax’s SD-101 drug in combination with Merck’s...

Dynavax Announces FDA Advisory Committee Vote in Favor of HEPLISAV-B

BERKELEY, CA--(Marketwired - July 28, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Pro...

Dynavax Provides U.S. Regulatory Update on Heplisav-B Following FDA Advisory Committee Meeting

BERKELEY, CA -- (Marketwired) -- 08/03/17 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has requested more detailed information ab...

Vectura allows Dynavax access to smart inhalers

Vectura has signed an exclusive global agreement with Dynavax Technologies allowing use of its proprietary smart nebuliser technology to deliver an investigational immunotherapeutic to lung cancer pat...

Dynavax hepatitis B vaccine works; raises safety issues: FDA

(Reuters) - Dynavax Technologies Corp's experimental hepatitis B vaccine is effective, but there were more deaths and serious cardiac events in patients given the vaccine than in those given a rival p...

More Information Requested from Dynavax Concerning Hepatitis B Vaccine

NewsDynavax provides U.S. regulatory update on HEPLISAV-B following FDA advisory committee meeting. The FDA has delayed a decision on the hepatitis B vaccine, requesting further details about the prop...

Dynavax Technologies Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 11062017] Prices from USD $350

Dynavax Technologies Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Dynavax Technologies Corporation Mergers Acquisitions MA, Partnerships Al...

PubMed Articles [414 Associated PubMed Articles listed on BioPortfolio]

Advanced technologies for the remediation of pesticide-contaminated soils.

The occurrence of pesticides in soil has become a highly significant environmental problem, which has been increased by the vast use of pesticides worldwide and the absence of remediation technologies...

Enhancing the Gaming Experience Using 3D Spatial User Interface Technologies.

Three-dimensional (3D) spatial user interface technologies have the potential to make games more immersive and engaging and thus provide a better user experience. Although technologies such as stereos...

Technologies to Support Community-Dwelling Persons With Dementia: A Position Paper on Issues Regarding Development, Usability, Effectiveness and Cost-Effectiveness, Deployment, and Ethics.

With the expected increase in the numbers of persons with dementia, providing timely, adequate, and affordable care and support is challenging. Assistive and health technologies may be a valuable cont...

3D Metal Printing - Additive Manufacturing Technologies for Frameworks of Implant-Borne Fixed Dental Prosthesis.

An edentulous patient was rehabilitated with maxillary metal-ceramic and mandibular metal-resin implant-supported fixed dental prosthesis (FDP). Metal frameworks of the FDPs were fabricated using 3D a...

Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.

The utility of the levels of amyloid beta (Aβ) peptide and tau in blood for diagnosis, drug development, and assessment of clinical trials for Alzheimer's disease (AD) has not been established. The l...

Clinical Trials [308 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Longitudinal Study of Chronic Wounds Using Novel Wound Measurement Technologies

An open, non-randomised longitudinal study of diabetic foot ulcers receiving standardised treatment, over a 16 week period conducted at out-patient level, utilising novel optical wound mea...

Companies [1220 Associated Companies listed on BioPortfolio]

Dynavax Technologies

Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative therapeutic products to treat and prevent infectious diseases, allergies, and cancer. Our versatile, prop...

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

CA Technologies

CA Technologies (NASDAQ: CA) is an IT management software and solutions company with expertise across all IT environments - from mainframe and distributed, to virtual and cloud. For additional inf...

SensiQ Technologies, Inc.

SensiQ Technologies, Inc. develops and manufactures innovative tools for the advancement of life sciences research. SensiQ Technologies offers a suite of instruments and platforms...

eLum Technologies, Inc.

eLum Technologies, Inc. is an early stage medical device company based in California. eLum Technologies is focused on disruptive technologies to address endovascular diseases. ...

More Information about "Dynavax Technologies" on BioPortfolio

We have published hundreds of Dynavax Technologies news stories on BioPortfolio along with dozens of Dynavax Technologies Clinical Trials and PubMed Articles about Dynavax Technologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dynavax Technologies Companies in our database. You can also find out about relevant Dynavax Technologies Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record